LifeMD
Stock Forecast, Prediction & Price Target
LifeMD Financial Estimates
LifeMD Revenue Estimates
LifeMD EBITDA Estimates
LifeMD Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $92.87M N/A | $119.03M 28.16% | $152.54M 28.15% | Avg: $254.74M Low: $248.54M High: $258.87M avg. 66.99% | Avg: $295.3M Low: $289.65M High: $301.47M avg. 15.91% | ||
Net Income
% change YoY
| $-61.32M N/A | $-45.02M 26.58% | $-20.59M 54.25% | Avg: $3.83M Low: $-8.13M High: $26.78M avg. 118.62% | Avg: $-1.7M Low: $-12.18M High: $-11.57M avg. -144.31% | ||
EBITDA
% change YoY
| $-49.43M N/A | $-32.21M 34.83% | $-8.21M 74.50% | Avg: $-104.93M Low: $-106.62M High: $-102.37M avg. -1177.41% | Avg: $-121.63M Low: $-124.17M High: $-119.31M avg. -15.91% | ||
EPS
% change YoY
| -$2.27 N/A | -$1.45 36.12% | -$0.7 51.72% | Avg: $0.13 Low: -$0.24 High: $0.79 avg. 118.85% | Avg: -$0.35 Low: -$0.36 High: -$0.34 avg. -365.15% | ||
Operating Expenses
% change YoY
| $129.18M N/A | $140.05M 8.41% | $148.46M 6.00% | Avg: $321.20M Low: $313.38M High: $326.41M avg. 116.35% | Avg: $372.34M Low: $365.23M High: $380.12M avg. 15.91% | ||
FAQ
What is LifeMD stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -12.84% in 2025-2026.
We have gathered data from 3 analysts. Their low estimate is -8.13M, average is 3.83M and high is 26.78M.
What is LifeMD stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 41.45% in 2025-2026.
We have gathered data from 4 analysts. Their low revenue estimate is $248.54M, average is $254.74M and high is $258.87M.
What is LifeMD stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -123.14% in 2025-2026.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$0.24, average is $0.13 and high is $0.79.
What is the best performing analyst?
In the last twelve months analysts have been covering LifeMD stock. The most successful analyst is Kyle Bauser.